Israel Englander Protara Therapeutics, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 568,421 shares of TARA stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

568,421

Previous 371,453 53.03%

Holding current value

$1.8 Million

Previous $1.95 Million 24.15%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$3.37 - $6.14 $663,782 - $1.21 Million	196,968 Added 53.03%	568,421 $2.42 Million
Q4 2024 Feb 14, 2025	BUY	$1.68 - $7.53 $599,845 - $2.69 Million	357,051 Added 2479.18%	371,453 $1.95 Million
Q3 2024 Nov 14, 2024	BUY	$1.7 - $2.4 $24,483 - $34,564	14,402 New	14,402 $26,000
Q4 2023 Feb 14, 2024	SELL	$1.12 - $1.93 $14,607 - $25,171	-13,042 Reduced 53.13%	11,506 $21,000
Q2 2023 Aug 14, 2023	SELL	$2.27 - $3.59 $4,024 - $6,365	-1,773 Reduced 6.74%	24,548 $58,000
Q1 2023 May 15, 2023	SELL	$2.76 - $3.91 $9,121 - $12,922	-3,305 Reduced 11.16%	26,321 $82,000
Q4 2022 Feb 14, 2023	SELL	$2.43 - $3.7 $50,011 - $76,149	-20,581 Reduced 40.99%	29,626 $79,000
Q3 2022 Nov 14, 2022	SELL	$2.96 - $4.27 $31,307 - $45,163	-10,577 Reduced 17.4%	50,207 $149,000
Q2 2022 Aug 15, 2022	SELL	$2.8 - $5.33 $32,384 - $61,646	-11,566 Reduced 15.99%	60,784 $178,000
Q1 2022 May 16, 2022	SELL	$4.19 - $6.9 $142,020 - $233,875	-33,895 Reduced 31.9%	72,350 $370,000
Q4 2021 Feb 14, 2022	BUY	$6.15 - $7.76 $8,161 - $10,297	1,327 Added 1.26%	106,245 $717,000
Q3 2021 Nov 15, 2021	SELL	$6.38 - $9.3 $156,067 - $227,496	-24,462 Reduced 18.91%	104,918 $726,000
Q2 2021 Aug 16, 2021	BUY	$8.68 - $16.99 $601,055 - $1.18 Million	69,246 Added 115.15%	129,380 $1.26 Million
Q1 2021 May 17, 2021	BUY	$13.75 - $23.86 $67,031 - $116,317	4,875 Added 8.82%	60,134 $947,000
Q4 2020 Feb 16, 2021	BUY	$16.97 - $25.34 $294,107 - $439,167	17,331 Added 45.69%	55,259 $1.34 Million
Q3 2020 Nov 16, 2020	BUY	$16.76 - $31.89 $480,978 - $915,179	28,698 Added 310.92%	37,928 $638,000
Q2 2020 Aug 14, 2020	BUY	$22.0 - $60.7 $203,060 - $560,261	9,230 New	9,230 $271,000

Others Institutions Holding TARA

# of Institutions

Shares Held

28.4M

Call Options Held

365K

Put Options Held

108K

View Full List

About Protara Therapeutics, Inc.

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $35.7M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

More about TARA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account